133 related articles for article (PubMed ID: 31702033)
1. MicroRNA‑186‑5p mediates osteoblastic differentiation and cell viability by targeting CXCL13 in non‑traumatic osteonecrosis.
Xu W; Li J; Tian H; Wang R; Feng Y; Tang J; Jia J
Mol Med Rep; 2019 Nov; 20(5):4594-4602. PubMed ID: 31702033
[TBL] [Abstract][Full Text] [Related]
2. MiR-17-5p modulates osteoblastic differentiation and cell proliferation by targeting SMAD7 in non-traumatic osteonecrosis.
Jia J; Feng X; Xu W; Yang S; Zhang Q; Liu X; Feng Y; Dai Z
Exp Mol Med; 2014 Jul; 46(7):e107. PubMed ID: 25060766
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA‑186‑5p downregulation inhibits osteoarthritis development by targeting MAPK1.
Li Q; Wu M; Fang G; Li K; Cui W; Li L; Li X; Wang J; Cang Y
Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33537828
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of miR‑186 promotes the proliferation and drug resistance of glioblastoma cells by targeting Twist1.
Xiong Y; Chen R; Wang L; Wang S; Tu Y; Zhu L; Wang C
Mol Med Rep; 2019 Jun; 19(6):5301-5308. PubMed ID: 31059108
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA‑186‑5p is expressed highly in ethanol‑induced cardiomyocytes and regulates apoptosis via the target gene XIAP.
Liu Y; Yu B
Mol Med Rep; 2019 Apr; 19(4):3179-3189. PubMed ID: 30816481
[TBL] [Abstract][Full Text] [Related]
6. CXCL13 promotes the effect of bone marrow mesenchymal stem cells (MSCs) on tendon-bone healing in rats and in C3HIOT1/2 cells.
Tian F; Ji XL; Xiao WA; Wang B; Wang F
Int J Mol Sci; 2015 Jan; 16(2):3178-87. PubMed ID: 25647417
[TBL] [Abstract][Full Text] [Related]
7. miR‑186‑5p regulates the inflammatory response of chronic obstructive pulmonary disorder by targeting HIF‑1α.
Fu Y; Zhao J; Chen J; Zheng Y; Mo R; Zhang L; Zhang B; Lin Q; He C; Li S; Lin L; Xie T; Ding Y
Mol Med Rep; 2024 Feb; 29(2):. PubMed ID: 38214374
[TBL] [Abstract][Full Text] [Related]
8. Decrease of MiR-31 induced by TNF-α inhibitor activates SATB2/RUNX2 pathway and promotes osteogenic differentiation in ethanol-induced osteonecrosis.
Yu L; Xu Y; Qu H; Yu Y; Li W; Zhao Y; Qiu G
J Cell Physiol; 2019 Apr; 234(4):4314-4326. PubMed ID: 30132874
[TBL] [Abstract][Full Text] [Related]
9. Are CXCL13/CXCR5/FAK critical regulators of MSCs migration and differentiation?
Zhang Y; Ma C; Yu Y; Liu M; Yi C
Med Hypotheses; 2015 Mar; 84(3):213-5. PubMed ID: 25617044
[TBL] [Abstract][Full Text] [Related]
10. IL1beta and TNFalpha differently modulate CXCL13 chemokine in stromal cells and osteoblasts isolated from osteoarthritis patients: evidence of changes associated to cell maturation.
Lisignoli G; Cristino S; Toneguzzi S; Grassi F; Piacentini A; Cavallo C; Facchini A; Mariani E
Exp Gerontol; 2004 Apr; 39(4):659-65. PubMed ID: 15050303
[TBL] [Abstract][Full Text] [Related]
11. High glucose prevents osteogenic differentiation of mesenchymal stem cells via lncRNA AK028326/CXCL13 pathway.
Cao B; Liu N; Wang W
Biomed Pharmacother; 2016 Dec; 84():544-551. PubMed ID: 27693963
[TBL] [Abstract][Full Text] [Related]
12. CXCL13 drives spinal astrocyte activation and neuropathic pain via CXCR5.
Jiang BC; Cao DL; Zhang X; Zhang ZJ; He LN; Li CH; Zhang WW; Wu XB; Berta T; Ji RR; Gao YJ
J Clin Invest; 2016 Feb; 126(2):745-61. PubMed ID: 26752644
[TBL] [Abstract][Full Text] [Related]
13. MiR-378 overexpression attenuates high glucose-suppressed osteogenic differentiation through targeting CASP3 and activating PI3K/Akt signaling pathway.
You L; Gu W; Chen L; Pan L; Chen J; Peng Y
Int J Clin Exp Pathol; 2014; 7(10):7249-61. PubMed ID: 25400823
[TBL] [Abstract][Full Text] [Related]
14. Decreased osteogenic differentiation of mesenchymal stem cells in alcohol-induced osteonecrosis.
Suh KT; Kim SW; Roh HL; Youn MS; Jung JS
Clin Orthop Relat Res; 2005 Feb; (431):220-5. PubMed ID: 15685079
[TBL] [Abstract][Full Text] [Related]
15. microRNA-25 targets PKCζ and protects osteoblastic cells from dexamethasone via activating AMPK signaling.
Fan JB; Liu W; Zhu XH; Yi H; Cui SY; Zhao JN; Cui ZM
Oncotarget; 2017 Jan; 8(2):3226-3236. PubMed ID: 27911275
[TBL] [Abstract][Full Text] [Related]
16. CXCL13-CXCR5 co-expression regulates epithelial to mesenchymal transition of breast cancer cells during lymph node metastasis.
Biswas S; Sengupta S; Roy Chowdhury S; Jana S; Mandal G; Mandal PK; Saha N; Malhotra V; Gupta A; Kuprash DV; Bhattacharyya A
Breast Cancer Res Treat; 2014 Jan; 143(2):265-76. PubMed ID: 24337540
[TBL] [Abstract][Full Text] [Related]
17. Chemokine CXCL13 mediates orofacial neuropathic pain via CXCR5/ERK pathway in the trigeminal ganglion of mice.
Zhang Q; Cao DL; Zhang ZJ; Jiang BC; Gao YJ
J Neuroinflammation; 2016 Jul; 13(1):183. PubMed ID: 27401148
[TBL] [Abstract][Full Text] [Related]
18. Effects of Transplanting Bone Marrow Stromal Cells Transfected with CXCL13 on Fracture Healing of Diabetic Rats.
Jiang H; Wang Y; Meng J; Chen S; Wang J; Qiu Y; Zhao J; Guo T
Cell Physiol Biochem; 2018; 49(1):123-133. PubMed ID: 30134225
[TBL] [Abstract][Full Text] [Related]
19. MiR-217 promotes cell proliferation and osteogenic differentiation of BMSCs by targeting DKK1 in steroid-associated osteonecrosis.
Dai Z; Jin Y; Zheng J; Liu K; Zhao J; Zhang S; Wu F; Sun Z
Biomed Pharmacother; 2019 Jan; 109():1112-1119. PubMed ID: 30551361
[TBL] [Abstract][Full Text] [Related]
20. Dose-dependent inhibitory effects of zoledronic acid on osteoblast viability and function in vitro.
Huang X; Huang S; Guo F; Xu F; Cheng P; Ye Y; Dong Y; Xiang W; Chen A
Mol Med Rep; 2016 Jan; 13(1):613-22. PubMed ID: 26648136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
